the Correlation Between Non-invasive Indicators in Patients With Biliary Atresia

to Find Out Non-invasive Indices to Predict the Status of Hepatic Fibrosis in BA Patients. Clinical Trial

Official title:

the Correlation Between Hepatic Fibrotic Scores and ADC and Other Non-invasive Indicators in Patients With Biliary Atresia

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02848573
• Other study ID #: 201403098RINC
• Status: Completed
• Phase: N/A
• First received: July 26, 2016
• Last updated: July 26, 2016
• Start date: April 2008

Study information

• Verified date: July 2016
• Source: National Taiwan University Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: Taiwan : Food and Drug Administration
• Study type: Observational

Clinical Trial Summary

we propose this study and try to find out possible clinical applicable non-invasive imaging indices or its combination with the laboratory indices to predict the status of hepatic fibrosis in BA patients.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 41
• Est. primary completion date: June 2016
• Accepts healthy volunteers: No
• Gender: Both
• Age group: N/A to 30 Years

Eligibility

Inclusion Criteria:

• pathological proved diagnosis of biliary atresia, and without other distinct abnormality or malformations. All had undergone Kasai portoenterostomy. All of them received abdominal MRI study.

Exclusion Criteria:

• absence of laboratory data required.

Study Design

Observational Model: Cohort, Time Perspective: Retrospective

Related Conditions & MeSH terms

• Biliary Atresia
• to Find Out Non-invasive Indices to Predict the Status of Hepatic Fibrosis in BA Patients.

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
National Taiwan University Hospital

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	pathologic METAVIR fibrosis score		1 month	No